White & Case Advises Bank Syndicate on €780 Million Refinancing Of Cheplapharm Arzneimittel
Global law firm White & Case LLP has advised a bank syndicate on the €780 million refinancing of Cheplapharm Arzneimittel GmbH (Cheplapharm).
The transaction is comprised of a term loan B cov-light facility of €530 million with a seven-year term, and a revolving loan of €250 million with a six-year term.